Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2010-6-15
pubmed:abstractText
Although the choice of starting insulin for people with type 2 diabetes mellitus (T2DM) is often a basal or premix insulin analog, there is little evidence to base this decision on. This analysis aimed to determine if measurable clinical characteristics prior to starting insulin could predict differences in improved glycemic control between these options.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1473-4877
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1621-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20429817-Adult, pubmed-meshheading:20429817-Aged, pubmed-meshheading:20429817-Blood Glucose, pubmed-meshheading:20429817-Clinical Trials as Topic, pubmed-meshheading:20429817-Diabetes Mellitus, Type 2, pubmed-meshheading:20429817-Dosage Forms, pubmed-meshheading:20429817-Drug Administration Schedule, pubmed-meshheading:20429817-Drug Combinations, pubmed-meshheading:20429817-Drug Delivery Systems, pubmed-meshheading:20429817-Female, pubmed-meshheading:20429817-Hemoglobin A, Glycosylated, pubmed-meshheading:20429817-Humans, pubmed-meshheading:20429817-Hypoglycemia, pubmed-meshheading:20429817-Hypoglycemic Agents, pubmed-meshheading:20429817-Insulin, pubmed-meshheading:20429817-Male, pubmed-meshheading:20429817-Middle Aged, pubmed-meshheading:20429817-Postprandial Period, pubmed-meshheading:20429817-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: a pooled analysis of treat-to-target trials.
pubmed:affiliation
Tulane University Health Sciences Center, New Orleans, LA 70112, USA. vfonseca@tulane.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Meta-Analysis